1. CeO2 Nanoparticles-Loaded pH-Responsive Microparticles with Antitumoral Properties as Therapeutic Modulators for Osteosarcoma
- Author
-
Christos Tapeinos, Gianni Ciofani, Gabriele La Rosa, Alice Scarpellini, Mirko Prato, and Matteo Battaglini
- Subjects
musculoskeletal diseases ,General Chemical Engineering ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Article ,Surgical removal ,antineoplastic agents ,medicine ,Chemical Engineering (all) ,neoplasms ,microparticles ,Bone cancer ,business.industry ,Chemistry (all) ,apoptosis ,General Chemistry ,021001 nanoscience & nanotechnology ,medicine.disease ,0104 chemical sciences ,Cancer research ,cells ,Osteosarcoma ,nanoparticles ,Ceo2 nanoparticles ,0210 nano-technology ,business - Abstract
Osteosarcoma is an aggressive form of bone cancer mostly affecting young people. To date, the most effective strategy for the treatment of osteosarcoma is the surgical removal of the tumor with or without combinational chemotherapy. In this study, we present the development of a pH-sensitive drug-delivery system in the form of microparticles, with increased chemotherapeutic action against the osteosarcoma cell line SAOS-2, and with reduced toxicity against the heart myoblastic cell line H9C2. The delivery system is composed of calcium carbonate and collagen type I, and is loaded with cerium dioxide (CeO2) nanoparticles (3-based therapeutic modulators (C-TherMods)), which corresponds to 6.4 μg/mL of encapsulated doxorubicin, can protect the H9C2 cells even after 120 h, since the percentage of viable cells at this time point is 65%. On the contrary, when H9C2 cells are treated with 0.5 μg/mL of free doxorubicin, 75% of the cells are dead only after 24 h. When SAOS-2 cells are treated with the same concentration of C-TherMods (250 μg/mL), the viability of SAOS-2 cells is 80% after 24 h, while it reduces to 50% after 120 h. At pH 6.0, the synergic effect of the pro-oxidant CeO2 nanoparticles and of the encapsulated doxorubicin leads to almost 100% of cell death, even at the lowest concentration of C-TherMods (50 μg/mL).
- Published
- 2018
- Full Text
- View/download PDF